Establishing Global Drug Substance and Drug Product Specifications – What the Guidelines Don’t Tell You 2011
13 Jan 2011
Webinar
Learn how to establish global drug substance and drug product specifications that are appropriate to the phase of clinical development and market application, and understand the types of data that are needed to support these specifications.
Areas Covered in the Seminar:
ICH guidelines and other relevant sources for setting specifications.
Recent changes in compendial requirements.
Minimum requirements for drug substances from Phase 1 through market application.
Minimum requirement for drug products from Phase 1 through market application.
Specifications specific to various types of dosage forms.
Regional differences in specifications.
Data requirements for setting meaningful acceptance criteria.
ICH thresholds.
Impurity qualification.
Potential pitfalls due to insufficient or inappropriate specifications.
Who Will Benefit: This webinar will provide valuable assistance to all personnel in:
Pharmaceutical development project teams
Regulatory Affairs
Quality Assurance
Analytical and formulation development
Emerging pharmaceutical companies
Past Events
Establishing Global Drug Substance and Drug Product Specifications – What the Guidelines Don’t Tell You 2011 - 13 Jan 2011, Webinar (11847)
Establishing Global Drug Substance and Drug Product Specifications – What the Guidelines Don’t Tell You 2026
Important
Please, check "Establishing Global Drug Substance and Drug Product Specifications – What the Guidelines Don’t Tell You" official website for possible changes, before making any traveling arrangements
